SFTPA1 and lung carcinoma: Additionally, Grageda et al.43 found in tumor and peri-tumor tissue that expression of SFTPA2 mRNA and total SP-A protein was significantly lower in cancerous tissue compared to adjacent NC tissue (P < 0.001), suggesting that SFTPA2 could be a biomarker for lung cancer diagnosis.